Is risk-stratified breast cancer screening economically efficient in Germany?
Authors:
Open Access
- 23 May 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 14 (5) , e0217213
Abstract
Risk stratification has so far been evaluated under the assumption that women fully adhere to screening recommendations. However, the participation in German cancer screening programs remains low at 54%. The question arises whether risk-stratified screening is economically efficient under the assumption that adherence is not perfect. We have adapted a micro-simulation Markov model to the German context. Annual, biennial, and triennial routine screening are compared with five risk-adapted strategies using thresholds of relative risk to stratify screening frequencies. We used three outcome variables (mortality reduction, quality-adjusted life years, and false-positive results) under the assumption of full adherence vs. an adherence rate of 54%. Strategies are evaluated using efficiency frontiers and probabilistic sensitivity analysis (PSA). The reduced adherence rate affects both performance and cost; incremental cost-effectiveness ratios remain constant. The results of PSA show that risk-stratified screening strategies are more efficient than biennial routine screening under certain conditions. At any willingness-to-pay (WTP), there is a risk-stratified alternative with a higher likelihood of being the best choice. However, without explicit decision criteria and WTP, risk-stratified screening is not more efficient than biennial routine screening. Potential improvements in the adherence rates have significant health gains and budgetary implications. If the participation rate for mammographic screening is as low as in Germany, stratified screening is not clearly more efficient than routine screening but dependent on the WTP. A more promising design for future stratified strategies is the combination of risk stratification mechanisms with interventions to improve the low adherence in selected high-risk groups.Keywords
This publication has 45 references indexed in Scilit:
- Outcomes of Screening Mammography by Frequency, Breast Density, and Postmenopausal Hormone TherapyJAMA Internal Medicine, 2013
- Assessment of Clinical Validity of a Breast Cancer Risk Model Combining Genetic and Clinical InformationJNCI: Journal of the National Cancer Institute, 2010
- The efficiency frontier approach to economic evaluation of health‐care interventionsHealth Economics, 2010
- Health-related Quality of Life in Vacuum-Assisted Breast Biopsy: short-term effects, long-term effects and predictorsHealth and Quality of Life Outcomes, 2010
- Cost-Effectiveness Analysis of Anastrozole versus Tamoxifen in Adjuvant Therapy for Early-Stage Breast Cancer – A Health-Economic Analysis Based on the 100-Month Analysis of the ATAC Trial and the German Health SystemOnkologie, 2010
- European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary documentAnnals of Oncology, 2008
- Longitudinal Measurement of Clinical Mammographic Breast Density to Improve Estimation of Breast Cancer RiskJNCI: Journal of the National Cancer Institute, 2007
- Does worry about breast cancer predict screening behaviors? A meta-analysis of the prospective evidencePreventive Medicine, 2006
- Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: a meta-analytic reviewPreventive Medicine, 2004
- What is the relationship between breast cancer risk and mammography screening? A meta-analytic review.Health Psychology, 1996